Table 1.
Patient lab values at initial presentation (I), peak of illness (P), and most recent (R). Age at initial, peak, and most recent lab values provided in parentheses.
Phase | Bicarbonate | Lactate | Ammonia | CK | AST | ALT | PT/INR | PTT | Conjugated bilirubin | |
---|---|---|---|---|---|---|---|---|---|---|
Ref. range | 18–29 mmol/L | 0.5–1.6 mmol/L | 9–33 umol/L | 60–305 U/L | 20–64 U/L Patients 1–4 35–140 U/L Patients 5–6 |
12–42 U/L Patients 1–4 6–50 U/L Patients 5–6 | 10.9–13.4s / 0.8–1.2 | 22–36s | 0–0.3 mg/dL | |
Patient 1 | I (3m) | 11 | 12.7 | 11 | 60 | 151 | 87 | 16/1.32 | 34.7 | 0.2 |
P (3m) | 18.5 | 38 | 1383 (15m) | 376 | 165 | 21.4/1.86 | 46.6 | 0.1 | ||
R (41m) | 3.0 | <9 | 682 | 98 | 40 | 12.6/1.04 | 27.9 | 0.6 | ||
Patient 2 | I (2m) | 24 | 2.5 | 33 | 91 (1m) | 48 (1m) | 15.8/1.2 | 38 | 1.5 (1m) | |
P (6m) | 9.7 | 83 | 142 (10m) | 1322 | 918 | 16.2/1.6 | 38 (2m) | 1.5 (1m) | ||
R (10m) | 4.8 | 14 | 142 | 161 | 121 | 14.3/1.2 | 33.3 | 0.8 (10m) | ||
Patient 3 | I (2m) | 3.6 | 10.7 | <9 | 711 | 190 | 324 | 19.3/1.79 | 60.6 | 1.3 |
P (3m) | 19.3 (9w) | 393 | 4099 | 2615 | 503 | 43/4.26 | 192.4 | 20.9 | ||
R (3y) | 1.4 (19m) | 17 (13m) | 67 | 67 | 12.6/1.1 | 33 | 0 | |||
Patient 4 | I (2w) | 22 (3w) | 10.8 | 51 | 79 | 64 | 16.5/1.3 (3w) | 40.6 (3w) | <0.1 | |
P (3m) | 24.8 | 393 | 158 (2m) | 367 | 65 (5d) | 38.4/3.77 | 199.2 | 0.7 | ||
R (N/A) | ||||||||||
Patient 5 | I (<1w) | 7 | 14.8 | 165 | 221 | 89 | 24 | 15.1 / 1.2 (1m) | 32.0 (1m) | 0.0 |
P (2m) | >19.9 | 344 (<1w) | 1228 | 309 | 62.1 / 7.2 | 53.5 | 8.3 | |||
R (N/A) | ||||||||||
Patient 6 | I (<1w) | 16 | 5.7 | 17 | 64 | 24 | 15.7 / 1.2 | 35.7 | 0.0 | |
P (3m) | 41.9 | 90 (2m) | 73 (2m) | 540 | 347 | 19.7 / 1.6 | 34.8 (2m) | 8.5 | ||
R (15m) | 5.5 | 117 | 72 | 15.4 / 1.2 | 0.0 |
m: months, w: weeks. Reference ranges for PT/INR and PTT are approximate, as normal reference values vary in infancy.